Advertisement

Picture [iito] Made Without Love 650x80px
Organisation › Details

Sirion Biotech (Group)

SIRION Biotech was founded in Munich in 2006 with the idea of enabling novel cell models closer to reality than ever before. This required the assembly of an all-encompassing, novel viral vector platform. Both, designing de novo viral vectors and the subsequent creation of custom cell models will pave the way for superior compound development in the drug, cosmetics and food industries. SIRION's technologies have been validated in over 300 single projects with more than 100 academic and industrial partners. As a result, primary cell immortalizations have become highly reliable, as have de novo viral vectors to be used in gene therapy and vaccine applications. SIRION BIOTECH currently operates projects for most of the major pharmaceutical companies in Europe and USA and has ongoing collaborations with leading academic and governmental research institutes. *

 

Period Start 2005-01-01 start
  Today Sirion Biotech GmbH
Products Industry adenoviral vector
  Industry 2 lentiviral vector
Persons Person Lingelbach, Dieter (Sirion Biotech 201305 Managing Director (COO) before MorphoSys –200812c Head AbD Serotec)
  Person 2 Thirion, Christian (Sirion Biotech 201106 Managing Director + Founder)
     
Region Region Martinsried
  Country Germany
     
Basic data Employees A: 1 to 10 (2010-02-18)
     
    * Document for �About Section�: 
     
   
Record changed: 2020-11-23

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for Sirion Biotech (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80




» top